| Literature DB >> 19015760 |
Jason A Lachance, Christopher J Darus, Laurel W Rice.
Abstract
Endometrial carcinoma affects over 40,000 American women annually, making it the most common gynecologic malignancy. Over 80% of disease is diagnosed in the early stages, resulting in a generally favorable prognosis for most patients. However, discrepancies still exist with regard to primary surgical management and postoperative adjuvant therapies directed at reducing recurrence rates and improving survival. In this review, we outline the surgical management of newly diagnosed disease and review the risk factors that guide clinicians in the recommendation for postoperative adjuvant therapy.Entities:
Keywords: Chemotherapy; Endometrial cancer; Hysterectomy; Lymphadenectomy; Radiation
Year: 2008 PMID: 19015760 PMCID: PMC2582654
Source DB: PubMed Journal: Rev Obstet Gynecol ISSN: 1941-2797